Literature DB >> 11241267

The cytomorphology of ocular surface squamous neoplasia by using impression cytology.

G R Nolan1, L W Hirst, B J Bancroft.   

Abstract

BACKGROUND: The term ocular surface squamous neoplasia (OSSN) encompasses conjunctival and corneal intraepithelial neoplasia through to invasive squamous cell carcinoma of the ocular surface. The disease is related to prolonged exposure to solar ultraviolet light and has been proposed as an acquired immune deficiency syndrome-associated tumor. To the authors' knowledge, very few reports describing the cytology of these lesions have been published.
METHODS: Impression cytology (IC) samples collected from the eyes of patients with a range of ocular surface diseases were available for study. From these, 267 sets of impressions had subsequent histopathology that had been collected within 6 months of the IC, and which indicated the presence of OSSN. The IC from these cases was used to describe the cytomorphology of intraepithelial and invasive OSSN.
RESULTS: Within the intraepithelial group, keratinized dysplastic cells that often were accompanied by hyperkeratosis, syncytial-like groupings, and nonkeratinized dysplastic cells were described. Within the invasive group, cases with significant keratinization and an additional group of cases with little keratinization and sometimes also prominent macronucleoli were described. Keratinized cases were the most numerous in both the intraepithelial and invasive groups. A description also was given of a low number of cases with cytology and also subsequent histopathology indicating the presence of intraepithelial OSSN, in the absence of a clinically detectable lesion.
CONCLUSIONS: This detailed description of the cytomorphology of a high number of cases of OSSN with confirmation by histopathology should assist others with little experience of the cytology of these lesions to examine them with increased confidence. Cancer (Cancer Cytopathol) Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241267

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  The clinical value of in vivo confocal microscopy for diagnosis of ocular surface squamous neoplasia.

Authors:  Y Xu; Z Zhou; Y Xu; M Wang; F Liu; H Qu; J Hong
Journal:  Eye (Lond)       Date:  2012-03-09       Impact factor: 3.775

Review 2.  Impression cytology of the ocular surface.

Authors:  R Singh; A Joseph; T Umapathy; N L Tint; H S Dua
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

3.  In vivo confocal microscopy of ocular surface squamous neoplasia.

Authors:  R Parrozzani; D Lazzarini; A Dario; E Midena
Journal:  Eye (Lond)       Date:  2011-02-11       Impact factor: 3.775

4.  Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease.

Authors:  Lili Zhang; Zhitao Su; Zongduan Zhang; Jing Lin; De-Quan Li; Stephen C Pflugfelder
Journal:  JAMA Ophthalmol       Date:  2015-10       Impact factor: 7.389

5.  Role of Conjunctival Ultraviolet Autofluorescence in Ocular Surface Squamous Neoplasia.

Authors:  Saumya Yadav; Noopur Gupta; Rashmi Singh; Mukesh Patil; Rachna Meel; Murugesan Vanathi; Seema Kashyap; Radhika Tandon
Journal:  Ocul Oncol Pathol       Date:  2020-10-28

6.  Ocular surface tumors.

Authors:  Ihab Saad Othman
Journal:  Oman J Ophthalmol       Date:  2009-01

Review 7.  Anterior Segment Imaging in Ocular Surface Squamous Neoplasia.

Authors:  Sally S Ong; Gargi K Vora; Preeya K Gupta
Journal:  J Ophthalmol       Date:  2016-10-05       Impact factor: 1.909

8.  Impression Cytology in a Series of Clinically Diagnosed Ocular Surface Melanocytic Lesions.

Authors:  Mozhgan Rezaei Kanavi; Seyed Bagher Hosseini; Roshanak Aliakbar-Navahi; Hossein Aghaei
Journal:  J Ophthalmic Vis Res       Date:  2017 Jan-Mar

9.  Management Issues in Conjunctival Tumours: Ocular Surface Squamous Neoplasia.

Authors:  Victoria M L Cohen; Roderick F O'Day
Journal:  Ophthalmol Ther       Date:  2019-11-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.